Ventyx Biosciences, Inc. (VTYX) has a consensus analyst rating of Hold, based on 13 analysts covering the stock. Of those, 4 recommend buying, 9 recommend holding, and 0 recommend selling.
The analyst consensus price target for VTYX is $33.86, representing a +141.9% upside from the current price of $14. Price targets range from a low of $6.00 to a high of $60.00.